Who is sponsoring NCT04739631?

NCT04739631 is sponsored by Taipei Veterans General Hospital, Taiwan.

What drugs are being tested in NCT04739631?

Interventions in NCT04739631: acupuncture, minimal acupuncture.

What condition does NCT04739631 study?

NCT04739631 studies Chemotherapy-Induced Peripheral Neuropathy (CIPN).

Is NCT04739631 still recruiting?

NCT04739631 is currently status unknown. Last updated 27 April 2021.

Last reviewed 2021-04-27 · How we verify

NCT04739631

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Efficacy of Acupuncture on Chemotherapy-Induced Peripheral Neuropathy

Status unknown NA Last updated 27 April 2021

What this trial tests

NA trial testing acupuncture in Chemotherapy-Induced Peripheral Neuropathy (CIPN) in 94 participants. Status unknown.

Timeline

22 January 2021

Primary endpoint
30 June 2022

30 June 2022

Quick facts

Lead sponsor	Taipei Veterans General Hospital, Taiwan
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	94
Start date	22 January 2021
Primary completion	30 June 2022
Estimated completion	30 June 2022
Sites	1 location across Taiwan

Drugs / interventions tested

acupuncture — full drug profile →
minimal acupuncture

Conditions studied

Chemotherapy-Induced Peripheral Neuropathy (CIPN) — all drugs for Chemotherapy-Induced Peripheral Neuropathy (CIPN) →

Sponsor

Taipei Veterans General Hospital, Taiwan

Who can join

20 and older, any sex, with Chemotherapy-Induced Peripheral Neuropathy (CIPN). Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to assess the neurological efficacy of acupuncture in patients with cancer who experienced peripheral neuropathy, which is induced by chemotherapy.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Integrated Medicine for Chemotherapy-Induced Peripheral Neuropathy.
Tsai CH, Lin YH, Li YS, Ho TL, et al · · 2021 · cited 12× · PMID 34502166 · DOI 10.3390/ijms22179257
Emerging Approaches for the Management of Chemotherapy-Induced Peripheral Neuropathy (CIPN): Therapeutic Potential of the C5a/C5aR Axis.
Spera MC, Cesta MC, Zippoli M, Varrassi G, et al · · 2022 · cited 10× · PMID 36098939 · DOI 10.1007/s40122-022-00431-8

Verify or expand the search:

Other trials of acupuncture

Trials testing the same drug.

NCT07072442 — Integrative Chinese and Western Medicine for Knee Osteoarthritis · NA · not yet recruiting
NCT06982755 — Acupuncture Versus Compound Diclofenac Sodium for Pain Relief in Non-Traumatic Acute Abdominal · Phase 1, PHASE2 · not yet recruiting
NCT06922565 — Efficacy of Acupuncture in the Treatment of Moderate-to-severe Atopic Dermatitis · NA · not yet recruiting
NCT06707701 — Correlation Among Various OLGA and OLGIM Stages, Digestive Symptom Scores, and Acupuncture Treatment in Patients with Ch · not yet recruiting
NCT06713980 — Study on the Effects of Acupuncture in Patients with Cyclic Mastalgia · NA · not yet recruiting

Other Taipei Veterans General Hospital, Taiwan trials

Trials by the same sponsor.

NCT07463443 — Effectiveness of Chatbot for Improving Caregiving Outcomes in Primary Caregivers of Geriatric Pneumonia Patients: A Stud · NA · not yet recruiting
NCT07400757 — Statin and Vitamin D Treatment in Patients With Thyroid Eye Disease · NA · not yet recruiting
NCT07362134 — Pulsed-Field Ablation for Recurrent Atypical Atrial Flutter · NA · enrolling by invitation
NCT07473687 — Feasibility Study of Non-Contact Imaging-Based Physiological Monitoring in the Operating Room · recruiting
NCT07344207 — GUARD-PH: Guided Use of AI-ECG for Risk Detection of PH in Surgery (GUARD-PH Trial) · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04739631 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Taipei Veterans General Hospital, Taiwan
Last refreshed: 27 April 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04739631.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing